Clinical Evaluation Made Simple, Strategic, and Fully Compliant.

We develop, review, and update CEPs to ensure alignment with MDR, MEDDEV 2.7/1 Rev.4, and relevant MDCG guidance.
Evaluation of existing Clinical Evaluation Plans against MDR requirements, including scope, objectives, and planned methodologies.
Updating Clinical Evaluation Plans based on new regulations, notified body feedback, or changes in device risk classification.
Includes literature search strategy, data appraisal techniques, clinical evidence identification, and PMS/PMCF integration.
Covering Executive Summary, SOTA approach, Search Protocol, Data Appraisal, GSPR alignment, and PMS/PMCF strategy.
We provide complete CER writing, updates, and remediation services—covering literature evaluation, clinical data analysis, SOTA, and benefit–risk assessment.
Including all mandatory sections: Executive Summary, SOTA, Clinical Evidence Literature, PMS Summary, Risk Management, and Conclusion.
Ensuring alignment with MDCG guidelines, addressing NB queries, and integrating new clinical, PMS, and complaint data.
Mapping product claims with supporting clinical data and conducting structured benefit–risk assessments.
Comprehensive landscape review of current clinical practices, alternative treatments, and minimum benchmark performance standards.
Transparent screening, critical appraisal, and synthesis of clinical literature as per MEDDEV requirements.




Cetas Healthcare is the world’s leading boutique MedTech market research firm. We blend agency-grade research with strategic intelligence frameworks to track pipelines, regulatory shifts, clinical trials, and GTM strategies. As pioneers of ISO 14155-compliant PMCF surveys, we’ve managed 25,000+ patient case forms for Class II & III devices, helping clients secure CE certifications and stay ahead of EU MDR requirements.
Contact Us: communication@cetas-healthcare.com
Visit Our Pages